Lizama, Britney N.
Shin, Rick
North, Hilary A.
Look, Gary
Reaver, Aidan
Pandey, Kiran
Duong, Duc
Seyfried, Nicholas T.
Caggiano, Anthony O.
Hamby, Mary E. https://orcid.org/0000-0002-6782-1853
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF-021175)
Article History
Received: 7 April 2026
Accepted: 21 August 2026
First Online: 26 August 2026
Declarations
Ethical approval: All procedures and experimental protocols for these studies were approved by the University Health Network (UHN) Animal Care Committee under Animal Utilization Protocols #1738 (AAV-hA53T- -Syn) and #5074 (PFF- -Syn). All studies were performed according to the Animals for Research Act, the guidelines and policies of the Canadian Council on Animal Care (CCAC), and institutional policies.
Consent to participate: Not applicable as there were no human subjects.
Consent to publish: All authors have agreed to publish this manuscript.
Competing interests: BNL, AR, AOC, and MEH are or were employees and shareholders of Cognition Therapeutics. HAN, RS, and GL are or were consultants to Cognition Therapeutics. NTS, DD, and KP are or were co-founders, employees, consultants, and/or shareholders of EmTheraPro.